Trials / Unknown
UnknownNCT04285060
Safety and Efficacy of Samsung GEMS-H Device Training in Sub-Acute and Chronic Stroke
Safety and Efficacy on Functional Mobility Following Samsung GEMS-H Device Training in Sub-Acute and Chronic Stroke: A Pivotal Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Samsung Electronics · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
A single-site, interventional, single-arm trial to evaluate the safety and efficacy on functional mobility following Samsung GEMS-H (Gait Enhancing and Motivating System - Hip) device training in participants with sub-acute and chronic stroke.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Samsung GEMS-H | Subjects will participate in 18 sessions of training in the outpatient clinic with a licensed physical therapist. Therapy sessions will include 30 minutes of task specific training and another 15 minutes of the session can be used to focus on patient specific goal areas related to functional mobility and balance. Training sessions will occur 2-3 times a week for 6-8 weeks to complete the training protocol. |
Timeline
- Start date
- 2020-02-12
- Primary completion
- 2021-11-01
- Completion
- 2021-12-01
- First posted
- 2020-02-26
- Last updated
- 2021-09-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04285060. Inclusion in this directory is not an endorsement.